Condition
Postoperative Hematoma
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07302724Not ApplicableActive Not Recruiting
Drain Removal Before Versus After CPM in Primary Total Knee Arthroplasty
NCT05794321Phase 2RecruitingPrimary
Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy
NCT06575049Not Yet Recruiting
Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery
NCT03879499CompletedPrimary
Postoperative CRP Levels and Vaginal Cuff Hematoma
Showing all 4 trials